ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 812 filers reported holding ISHARES TR in Q3 2023. The put-call ratio across all filers is 3.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,026 | -3.7% | 1,955 | 0.0% | 0.03% | +6.2% |
| Q2 2023 | $248,154 | -1.7% | 1,955 | 0.0% | 0.03% | -33.3% |
| Q1 2023 | $252,447 | -19.4% | 1,955 | -18.0% | 0.05% | -36.8% |
| Q4 2022 | $313,078 | +2.0% | 2,385 | -9.2% | 0.08% | +22.6% |
| Q3 2022 | $307,000 | -1.3% | 2,626 | -0.6% | 0.06% | +10.7% |
| Q2 2022 | $311,000 | -11.9% | 2,643 | -2.4% | 0.06% | -17.6% |
| Q1 2022 | $353,000 | -14.5% | 2,709 | +0.0% | 0.07% | 0.0% |
| Q4 2021 | $413,000 | -48.3% | 2,708 | -45.2% | 0.07% | -65.8% |
| Q3 2021 | $799,000 | -98.5% | 4,944 | -98.5% | 0.20% | -97.9% |
| Q2 2021 | $54,090,000 | +7.3% | 330,522 | -0.6% | 9.34% | -4.4% |
| Q4 2020 | $50,394,000 | +16.5% | 332,655 | +0.4% | 9.77% | -21.8% |
| Q3 2020 | $43,259,000 | +6.5% | 331,179 | +11.4% | 12.50% | -11.8% |
| Q2 2020 | $40,625,000 | – | 297,206 | – | 14.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |